Wire
Parabilis Medicines Q2 Loss Narrows; Shares Rise Pre-Bell
Parabilis Medicines (PBLS) reported a Q2 loss Thursday $2.32 per diluted share, compared a loss of $22.28 a year earlier.Analysts from FactSet expected a loss of $0.36.Collaboration revenue for the quarter ended June 30 was $148,000. The company did not report any revenue a year ago.As of June 30, the company has cash, cash equivalents and marketable securities of $1.1 billion, which it said are expected to fund its operations into 2030.Shares of the company were up over 6% in Thursday's premarket activity.Price: $39.99, Change: $+2.58, Percent Change: +6.90%
$PBLS
